Literature DB >> 1987874

Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease.

D C Zoschke1, A A Skemp, D L Defosse.   

Abstract

OBJECTIVE: To compare lymphocyte proliferative responses to Borrelia burgdorferi in healthy controls and patients with Lyme disease. PATIENTS: Twelve patients fulfilling case-definition criteria for Lyme disease. Twelve healthy volunteers and two newborns served as controls. MEASUREMENTS: Antibodies to B. burgdorferi were measured by enzyme-linked immunosorbent assay (ELISA). Proliferation of peripheral blood lymphocytes cultured for 5 days with B. burgdorferi, recall antigens, or pokeweed mitogen was measured by radioactive thymidine uptake.
RESULTS: Lymphocytes from 11 patients with Lyme disease, 8 healthy seronegative controls, and two newborns showed elevated responses when stimulated with B. burgdorferi. When a patient and a control were studied on the same day, the patient's lymphocyte response to B. burgdorferi exceeded the control's in only 5 of 12 cases. Lymphocytes from both patients and controls responded to B. burgdorferi isolates from three different sources.
CONCLUSIONS: Heightened lymphocyte responses to B. burgdorferi are found in patients with Lyme disease but elevated responses also frequently occur in healthy controls. At present, the interpretation of a positive lymphocyte response to B. burgdorferi would be difficult in ambiguous clinical situations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987874     DOI: 10.7326/0003-4819-114-4-285

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  23 in total

Review 1.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

2.  Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis.

Authors:  B K DuChateau; J R Jensen; D M England; S M Callister; S D Lovrich; R F Schell
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Lymphoproliferative responses to Borrelia burgdorferi in the diagnosis of Lyme arthritis in children and adolescents.

Authors:  H I Huppertz; S Mösbauer; D H Busch; H Karch
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

4.  Antiscience and ethical concerns associated with advocacy of Lyme disease.

Authors:  Paul G Auwaerter; Johan S Bakken; Raymond J Dattwyler; J Stephen Dumler; John J Halperin; Edward McSweegan; Robert B Nadelman; Susan O'Connell; Eugene D Shapiro; Sunil K Sood; Allen C Steere; Arthur Weinstein; Gary P Wormser
Journal:  Lancet Infect Dis       Date:  2011-09       Impact factor: 25.071

Review 5.  Experimental immunization against Lyme borreliosis with recombinant Osp proteins: an overview.

Authors:  A Sadziene; A G Barbour
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

6.  Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice.

Authors:  L Yang; Y Ma; R Schoenfeld; M Griffiths; E Eichwald; B Araneo; J J Weis
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

7.  Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.

Authors:  K F Tai; Y Ma; J J Weis
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Long-term study of cell-mediated responses to Borrelia burgdorferi in the laboratory mouse.

Authors:  M S de Souza; A L Smith; D S Beck; G A Terwilliger; E Fikrig; S W Barthold
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification.

Authors:  J J Weis; Y Ma; L F Erdile
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Detection of IFN-γ Secretion by T Cells Collected Before and After Successful Treatment of Early Lyme Disease.

Authors:  Steven M Callister; Dean A Jobe; Aleksandra Stuparic-Stancic; Misato Miyamasu; Jeff Boyle; Raymond J Dattwyler; Paul M Arnaboldi
Journal:  Clin Infect Dis       Date:  2016-03-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.